Placebo response in the treatment of panic disorder

Robert M A Hirschfeld

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

A review of key placebo-controlled studies of benzodiazepines and selective serotonin reuptake inhibitors (SSR Is) over the past decade challenges the widespread view that placebo response rates resulting from clinical trials of pharmacotherapy for panic disorder are excessively high. Statistically and clinically significant drug-placebo differences have been demonstrated in large-scale trials. Further research is needed on the impact of pharmacological treatments on the medium- and long-term course of the disorder.

Original languageEnglish (US)
JournalBulletin of the Menninger Clinic
Volume60
Issue number2 SUPPL.
StatePublished - Mar 1996

Fingerprint

Panic Disorder
Placebos
Serotonin Uptake Inhibitors
Benzodiazepines
Therapeutics
Clinical Trials
Pharmacology
Drug Therapy
Research
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Placebo response in the treatment of panic disorder. / Hirschfeld, Robert M A.

In: Bulletin of the Menninger Clinic, Vol. 60, No. 2 SUPPL., 03.1996.

Research output: Contribution to journalArticle

Hirschfeld, Robert M A. / Placebo response in the treatment of panic disorder. In: Bulletin of the Menninger Clinic. 1996 ; Vol. 60, No. 2 SUPPL.
@article{b3c962f238894f99ad6adafc7466d6e0,
title = "Placebo response in the treatment of panic disorder",
abstract = "A review of key placebo-controlled studies of benzodiazepines and selective serotonin reuptake inhibitors (SSR Is) over the past decade challenges the widespread view that placebo response rates resulting from clinical trials of pharmacotherapy for panic disorder are excessively high. Statistically and clinically significant drug-placebo differences have been demonstrated in large-scale trials. Further research is needed on the impact of pharmacological treatments on the medium- and long-term course of the disorder.",
author = "Hirschfeld, {Robert M A}",
year = "1996",
month = "3",
language = "English (US)",
volume = "60",
journal = "Bulletin of the Menninger Clinic",
issn = "0025-9284",
publisher = "Guilford Publications",
number = "2 SUPPL.",

}

TY - JOUR

T1 - Placebo response in the treatment of panic disorder

AU - Hirschfeld, Robert M A

PY - 1996/3

Y1 - 1996/3

N2 - A review of key placebo-controlled studies of benzodiazepines and selective serotonin reuptake inhibitors (SSR Is) over the past decade challenges the widespread view that placebo response rates resulting from clinical trials of pharmacotherapy for panic disorder are excessively high. Statistically and clinically significant drug-placebo differences have been demonstrated in large-scale trials. Further research is needed on the impact of pharmacological treatments on the medium- and long-term course of the disorder.

AB - A review of key placebo-controlled studies of benzodiazepines and selective serotonin reuptake inhibitors (SSR Is) over the past decade challenges the widespread view that placebo response rates resulting from clinical trials of pharmacotherapy for panic disorder are excessively high. Statistically and clinically significant drug-placebo differences have been demonstrated in large-scale trials. Further research is needed on the impact of pharmacological treatments on the medium- and long-term course of the disorder.

UR - http://www.scopus.com/inward/record.url?scp=0029979893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029979893&partnerID=8YFLogxK

M3 - Article

C2 - 8857428

AN - SCOPUS:0029979893

VL - 60

JO - Bulletin of the Menninger Clinic

JF - Bulletin of the Menninger Clinic

SN - 0025-9284

IS - 2 SUPPL.

ER -